References

Papers produced and published by the outcome measures group;

  • Davidson SE, Burns M, Routledge J, West CML, Swindell R, Logue JP, Wylie J, Slevin NJ, Cowan RA, Magee.B, Harris MA. Short report: A morbidity scoring scheme for clinical oncology practice: Questionnaires produced from the LENT SOMA scoring system. Clin.Oncol. 2002; 14:68-69.
  • Appel W, West CML, Davidson SE. Grand round: Late morbidity in a patient with carcinoma of the cervix. Clin. Oncol. 2002; 14:437-41.
  • Davidson SE. Assessment of treatment -related morbidity in gynaecological malignancy. Cancer Topics 2002; 11:16-18.
  • Livsey JE, Routledge J, Burns M, Swindell R, Davidson SE, Cowan RA, Logue JP, Wylie J. Scoring of treatment related late effects in prostate cancer. Radiother.Oncol. 2002; 65:109-121.
  • Routledge JA, Burns MP, Swindell R, Khoo VS, West CML, Davidson SE. Evaluation of the LENT SOMA scales for the prospective assessment of treatment morbidity in cervical carcinoma. Int JRadiat.Oncol.Biol.Phys.2003; 56:502-510.
  • Davidson SE, Burns M, Routledge J, Swindell R.The impact of radiotherapy for carcinoma of the cervix on sexual function assessed using the LENT SOMA scales. Radiother.Oncol. 2003; 68:241-7.
  • Wilkinson JM, Harris MA, Davidson SE, Welch RS, Hunter RD, Swindell R. A retrospective study of bladder morbidity in patients treated with intracavitary brachytherapy for cervix cancer. BJR 2003; 897-903.
  • Davidson SE, Burns MP, Routledge JA, Swindell R, Bentzen S, West CML. Assessment of morbidity in carcinoma of the cervix: a comparison of the LENT SOMA scales and the Franco-Italian Glossary. Radiother.Oncol. 2003; 69:195-200.
  • Ataman OU, Barrett A, Davidson SE, et al. Audit of effectiveness of routine follow-up clinics after radiotherapy for cancer a report of the REACT working group of ESTRO. Radiother.Oncol. 2004; 237-249.
  • Jain P, Hunter RD, Livsey JE, Coyle C, Kitchener HC, Swindell R, Davidson SE. Pattern of failure and long term morbidity in patients undergoing postoperative radiotherapy for cervical cancer. Int J Gynecol Cancer. 2006; 16(5):1839-45.
  • Davidson SE, Faithfull S. Late Radiotherapy Effects: Is bowel morbidity adequately documented or patients' needs managed appropriately? Editorial Clin Oncol. 2006; 18:419-20.
  • Burns M, Costello J, Ryan-Woolley B, Davidson SE, Assessment of impact of late treatment effects in cervical cancer: an explorational study of women's sexualityEur J Cancer Care 2007; 16(4):364-72.
  • Kelly K, Swindell R, Routledge J, Burns M, Logue J P, Wylie J P. Prediction of urinary symptoms after 125iodine prostate brachytherapy. Clinical Oncol. 2006; 18(4):326-32.
  • Davidson SE, Trotti A, Ataman OU, Seong J, Lau FN, daMotta NW, Jeremic B. Improving the capture of adverse event data in clinical trials: the role of the International Atomic Energy Agency. Int J Radiat Oncol Bio Phys 2007 In press.
  • Davidson SE, Trotti A, Ataman OU, Seong J, Lau FN, daMotta NW, Jeremic B. Improving the capture of adverse event data in clinical trials: the role of the International Atomic Energy Agency. Int J Radiat Oncol Biol Phys 2007; 69:1218-21.
  • West CML, Davidson SE. Measurement for gastrointestinal symptoms in radiation oncology. Curr. Opinion in Supportive and Palliative Care 2009; 3:36-40.
  • Barker CL, Routledge JA, Farnell DJJ, Swindell R, Davidson SE. The impact of radiotherapy late effects on quality of life in gynaecological cancer patients. BJC 2009; 100(10):1558-65.
  • Ho K, Farnell DJJ, Routledge JA, Burns MP, Sykes AJ, Slevin NJ, Davidson SE. Developing a CTCAE patient questionnaire for late toxicity after head and neck radiotherapy Eur J Cancer 2009; 45:1992-8.
  • Farnell DJJ, Routledge JA, Hannon R, Logue JP, Cowan RA, Wylie JP, Barraclough LH, Livsey JE, Swindell R, Davidson SE. Efficacy of Data Capture for Patient-Reported Toxicity Following Radiotherapy Treatment for Prostate or Cervical Cancer Eur J Cancer 2010; 46:534-540.
  • Ho K, Farnell DJJ, Routledge JA, Burns MP, Sykes AJ, Slevin NJ, Davidson SE. Comparison of Patient-Reported Late Treatment Toxicity (LENT-SOMA) with Quality of Life (EORTC C30 and C35) assessment after Head and Neck Radiotherapy Radiother.Oncol. 2010; 97:270-5.
  • Farnell DJJ, Mandell P, Anandadas C, Routledge JA, Burns MP, Logue JP, Wylie JP, Swindell R, Livsey JE, West CML, Davidson SE. Development of a Patient-Reported Questionnaire for Collecting Toxicity Data following Prostate Brachytherapy Radiotherapy and Oncology. Radiother.Onocl. 2010; 97:136-142.
  • Anandadas CA, Clarke NW, Davidson SE, O'Reilly PH, Logue JP, Gilmore L, Swindell R, Brough RJ, Wemyss-Holden GD, Lau MW, Javle PM, Ramani VAC, Wylie JP, Collins GN, Brown S, Cowan RA. Early prostate cancer which treatment do men prefer and why? BJ Urol. 2011; 107:1762-8.
  • Henson CC, Andreyev HJ, Symonds RP, Peel D, Swindell R, Davidson SE. Late onset bowel dysfunction after pelvic radiotherapy: A national survey of current practice and opinions of clinical oncologists Clin Oncol (R Coll Radiol). 2011; 23:552-557.
  • Henson CC, Davidson SE. After the cure: gastrointestinal problems in cancer survivors Primary Care Women's Health Journal 2011; In press.
  • Anandadas CA, Davidson SE, Clarke NW, O'Reilly PH, Logue JP, Gilmore L, Swindell R, Brough RJ, Wemyss-Holden GD, Lau MW, Javle PM, Ramani VAC, Wylie JP, Collins GN, Brown S, Cowan RA. Quality of Life in men treated for early prostate cancer: A prospective patient preference cohort study. J.Cancer Therapy 2011; In press.
  • Henson C, Davidson SE, Lalji A, Symonds P, Swindell R, Andreyev J. Gastrointestinal symptoms after pelvic radiotherapy: a national survey of gastroenterologists. J Support.Care.Cancer. 2011; In press.
  • Andreyev J, Davidson S, Gillespie C, Allum W, Swarbrick E Practice guidance on the management of acute and chronic gastrointestinal problems arising as a result of treatment for cancer. Gut 2011; in press.
  • Barraclough LH, Routledge JA, FarnellDJ, BurnsMP, Swindell R, Livsey J, Davidson SE. Prospective analysis of patient-reported late toxicity following pelvic radiotherapy in patients with gynaecological cancer. Radiother.Oncol.2012; in press.
  • Joseph LA, Routledge JA, Burns MP, Swindell R, Sykes AJ, Slevin NJ, Davidson SE. The value of the Hospital Anxiety and Depression Scale in the follow-up of head and neck cancer patients. JLO 2012; in press.

Last updated: March 2022

Christie stories during the COVID-19 pandemic

During the COVID-19 pandemic, we're doing all we can to make sure patients get the treatment, information and support they need. Read some stories from our patients and staff to find out what The Christie is doing at this difficult time.

View All
Corinne Faivre Finn
“We have seen a lot of our research staff return to the office. This has massively improved morale as it is a lot easier to connect with people.”
Corinne Faivre-Finn, Christie consultant
Read More
Read More
profile placeholder image
“The experience has allowed me to be able to hear what is not being said. The extraordinary strength and resilience of individuals as they greet you with a smile… when you are aware of the pain and anguish they will be going through.”
Digital services team, redeployed to telephone patients
Read More
Read More
“Of course, the COVID-19 virus has not gone away – we have to be cautious and we have to proceed in an appropriate way.”
Professor John Radford, director of research at The Christie
Read More
Read More